The stock price is simply ridiculous. Even if a generic Dacogen was a CERTAINTY (which its not) with EU orphan drug status for 10 years, 130 mil in cash , broadening of the SGI 110 clinical trials . Reports coming on HSP 90 this price is RIDICULOUS.. I am buying somemore right here at 2.19..
My only explanation for this price is the Management team is hated (not too strong a word) and has zero credIbility .